PD-L1 upregulation on tumor cells may be the manifestation of an adaptive immune resistance induced by CD8+ lymphocytes via γ interferon secretion or by an intrinsic resistance due to oncogenic signaling. The gene discussed is CD8A; the disease is neoplasm.